
Edinburgh-based drug discovery firm AdoRx therapeutics has signed a deal with US healthcare conglomerate Johnson & Johnson to develop novel …

Almost half of all children with cancer are going untreated and undiagnosed, according to research published in Lancet Oncology. While …

The Justice Department and US Securities and Exchanges Commission are investigation healthcare giant Johnson & Johnson over allegations that Johnson’s …

Smoking may limit the body’s ability to fight melanoma, according to a study published in the journal Cancer Research. The …

Merck & Co’s Keytruda (pembrolizumab) in combination with Pfizer’s Inlyta (axitinib) significantly extended the lives of those with advanced renal …

Researchers at the Medical University of South Carolina (MUSC) have discovered a new type of cell membrane complex which causes …

British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal …

Roche’s Genentech unit has agreed to pay $120 million upfront as part of a research and licensing deal with California-based …

Cancers related to obesity are on the rise in young adults, according to findings from the American Cancer Society, published …

Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …

An Israeli biotech has claimed that it has developed a complete cure for cancer. Speaking to the Jerusalem Post, Dan …

Adults diagnosed with stage 1 skin, prostate or breast cancer have the same chance of still being alive the following …

British multinational GlaxoSmithKline (GSK) have acquired US oncology firm Tesaro for $5.1 billion (£4 billion). Tesaro, a Massachusetts-based clinical stage …

Health Canada has approved Novartis’ CAR-T therapy Kymriah for use in paediatric and young adult patients aged between three and …

Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between …